Yahoo
OTC Markets OTCPK - Delayed Quote USD

Boiron SA (BOIRF)

31.50 0.00 (0.00%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for BOIRF
  • Previous Close 31.50
  • Open 31.50
  • Bid 19.30 x 20000
  • Ask 22.15 x 10000
  • Day's Range 31.50 - 31.50
  • 52 Week Range 30.00 - 32.27
  • Volume 200
  • Avg. Volume 0
  • Market Cap (intraday) 546.912M
  • Beta (5Y Monthly) 0.27
  • PE Ratio (TTM) 17.90
  • EPS (TTM) 1.76
  • Earnings Date --
  • Forward Dividend & Yield 1.57 (4.98%)
  • Ex-Dividend Date Jun 3, 2026
  • 1y Target Est --

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices (in vitro diagnostics), dietary supplements, herbal remedies, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sedative PC Granules to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. Further, the company provides Quietude, Rhinallergy, Ribes Nigrum Macerate Glycerin 1 DH Boiron, Sabal serrulata Mother Tincture Boiron, Sevameo, Sinupyl, Sportenine, Stodaline Sugar-Free, Stodal Granules, Stodal Syrup, Storinyl, Sedative PC Sublingual Tablet, Tilia Tomentosa Glycerinated Macerate 1DH Boiron, Varesol, Verrulia, Avenoc Suppository, Calendula Cream, Zelaceo, and Zenalia. It offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is based in Messimy, France.

www.boiron.fr

2,623

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

BOIRF
5.00%
CAC 40 (^FCHI)
2.21%

1-Year Return

BOIRF
28.57%
CAC 40 (^FCHI)
2.30%

3-Year Return

BOIRF
18.78%
CAC 40 (^FCHI)
16.77%

5-Year Return

BOIRF
12.01%
CAC 40 (^FCHI)
16.68%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY23
Revenue 132.25M
Earnings --
Profit Margin 0.00%

Q1

FY23

Q2

FY23

Q3

FY23

Q4

FY23

0
50M
100M
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.28%

  • Return on Assets (ttm)

    4.33%

  • Return on Equity (ttm)

    7.04%

  • Revenue (ttm)

    495.78M

  • Net Income Avi to Common (ttm)

    26.19M

  • Diluted EPS (ttm)

    1.76

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    50.67M

  • Total Debt/Equity (mrq)

    6.34%

  • Levered Free Cash Flow (ttm)

    27.55M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: